Recruiting

Radiosurgery

Sponsor:

Jonsson Comprehensive Cancer Center

Code:

NCT07605546

Conditions

Cancer Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Radiosurgery

Study Details

Brief summary:

The investigators propose to conduct a study in medically refractory cancer pain patients utilizing radiosurgery to ablate the pituitary hypophysis, as well as neuromodulate the centromedian and parafascicular complexes within the thalami - the so-called triple target. This involves treating the pituitary hypophysis and thalamus to a dose of 90 Gy. These patients will have previously failed to achieve adequate pain control with opioid pain regimens and interventional approaches. The trial will involve a multidisciplinary approach involving radiation oncology, neurosurgery, palliative care, and medical oncology colleagues across UCLA.

Conditions

Cancer Pain

Study ID

NCT07605546

Start date

Jun 9, 2026

Status verified date

Jun, 2026

Completion date

Jun 1, 2029

Anticipated

Primary completion date

Jun 1, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Male or female ≥ 18 years of age on day of SRS treatment.
2. Documentation of insufficiently controlled mixed, complex cancer pain based on Brief Pain Inventory (BPI) >8/10 despite optimization of opioid regimen
3. Not eligible for or willing to undergo further pain-relieving interventions
4. Written informed consent (and assent when applicable) obtained from patient or patient's legal representative and ability for patient to comply with the study requirements and agree to undergo the study's SRS treatment plan.

Exclusion Criteria:

1. Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study.
2. Claustrophobia or inability to life flat
3. Inability to undergo routine imaging studies
4. Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
5. Current history of intracranial malignancy or brain metastasis
6. Any prior intracranial irradiation
7. Previous history of craniotomy, deep brain stimulation (DBS) or laser interstitial themal therapy (LITT).
8. Presence of intracranial hardware such as leads for DBS or any other material that may interfere with safe treatment.
9. Any comorbidity or condition which would limit full compliance with the protocol

Study Design

Enrollment

19 participants

Anticipated

Intervention Model

Single group

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: Treatment

intracranial functional stereotactic radiosurgery (FnSRS) to the centromedian-parafasciular complex bilaterally, and the hypophysis.

Interventions

Radiosurgery

intracranial functional stereotactic radiosurgery (FnSRS) to the triple target: centromedian-parafasciular complex bilaterally, and the hypophysis

Primary outcome measure

  • Pain Inventory [ Time Frame: - Baseline: Daily measurements on three separate days prior to treatment (Day -7 +/- 3 days, Day -3 +/- 1 day, Day -2 +/- 1 day)- Post-baseline: Days +1, 2, 3, 4, 7, 14, 21, 28 ]

Central Contacts and Locations

Locations

UCLA / Jonsson Comprehensive Cancer Center

Recruiting

Los Angeles, California, United States, 90095

Contacts

More Information

Sponsor

Jonsson Comprehensive Cancer Center

Last update posted

Jul 8, 2026

Last verified

Jun, 2026

Keywords

  • reduction

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Jonsson Comprehensive Cancer Center on 2026-07-08.